Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

TEST KIT, CORONAVIRUS D

Active
SPE2DS-26-T-352TFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSFView Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

ATTN CL VIII MED REQ PROCES ACT, APO, AE, 09227-0000, USA

Set-Aside

NONE

Documents

(1)

SPE2DS-26-T-352T.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF
View Agency Profile
Office AddressUSA

Full Description

Show more
TEST KIT,CORONAVIRUS DETECTION
TEST KIT, CORONAVIRUS DETECTION
QUICKVUE AT-HOME OTC COVID-19 TEST;
ANTERIOR NARES SWAB; DIPSTICK TEST FORMAT;
RESULTS IN 10 MINUTES; TWO-COLOR RESULTS
BLUE CONTROL LINE AND RED TEST LINE; EASY
TO READ AND INTERPRET; ALL COMPONENTS
INCLUDED IN KIT READY TO USE; NO NEED FOR
ADDITIONAL EQUIPMENT; CONTAINS BUILT-IN
PROCEDURAL CONTROL FEATURES; KIT CONTAINS
SUPPLIES TO RUN TWO TESTS; KIT CONTAINS
TUBE HOLDER (1), PREFILLED TUBE (2), SWAB
(2), TEST STRIP (2). INTENDED FOR ONE
PERSON TO RUN TEST TWICE WITH 24-36 HOURS
IN BETWEEN TESTS.
.
UNIT OF ISSUE: KIT
.
..
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
..
ADEQUATE DATA FOR THE NSN/Part Number: 6550-01-697-6662 Quantity: 25 KT Purchase Request: 7017943349QTY: 25 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325413
New
Federal
6640--LAB - Immunochemistry (IHC) instrument
Solicitation # 36C24226Q0827
The Department of Veterans Affairs, through Network Contracting Office 2, intends to award a sole-source contract to Roche Diagnostics Corporation for proprietary reagent kits and consumables compatible with VA-owned Roche Benchmark Ultra Plus immunohistochemistry instruments. This action is justified under FAR 6.302-1 due to the technical exclusivity of the reagents, as no alternative suppliers can provide products that function with the existing VA equipment. The solicitation, identified by number 36C24226Q0827, was posted on July 22, 2026, with responses due by July 30, 2026, at 10:00 a.m. Eastern Time, submitted exclusively via email to the Contracting Officer, Aleta Jennette. The contract is for laboratory reagents essential to ongoing diagnostic operations, primarily at the James J. Peters VA Medical Center in Bronx, NY, though the final place of performance remains TBD. No competitive solicitation exists, and therefore no formal evaluation factors, pricing details, line items, or contract value have been established. The procurement is non-competitive, with no set-asides for small or socioeconomic businesses, and no socioeconomic certifications or UEI/CAGE codes for the vendor are provided. Packaging, marking, preservation, inspection, acceptance criteria, and invoicing methods are not specified, with assumed compliance to standard commercial practices for laboratory reagents. Contract administration oversight is limited to the Contracting Officer, with no designated COR, COTR, or PCO identified. The contracting office is located in Albany, NY, but administrative and performance functions are centered at the Bronx facility. No FAR clauses, special requirements, or representations from the offeror are included, as the document serves solely as a market research notice indicating intent to award without requiring formal proposals, quotes, or submissions other than expressions of interest. The acquisition is driven entirely by proprietary compatibility, with no alternatives available, rendering traditional contract elements such as pricing, delivery schedules, or payment terms unnecessary at this preliminary stage.
242-NETWORK Contract Office 02 (36C242)

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 325413
New
Federal
BRAND NAME OR EQUAL Flow Cytometry Reagents for the MPLS VA
Solicitation # 36C26326R0072
Solicitation 36C26326R0072 is a five-year Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract issued by the Department of Veterans Affairs, Network Contracting Office 23, for the procurement of brand-name or equal flow cytometry reagents. The contract is designed to support clinical immunophenotyping at the Minneapolis VA Health Care System, with a total period of performance running from October 1, 2026, through September 30, 2031. This duration consists of a base period followed by four one-year ordering periods. The procurement is justified as a sole-source award under FAR 6.103-1 and 12.102(a) because the required Becton Dickinson (BD) reagents are proprietary and the only products compatible with the facility's existing BD FACSCanto, FACSLyric, and FACS Lyse Wash Assistant instrumentation. The scope of work involves the supply of a specific catalog of BD reagents, including various CD antigens and fluorochromes, with estimated annual quantities ranging from 2 to 60 units per item. All deliveries and performance will occur at the Minneapolis VA Health Care System located at One Veterans Drive, Minneapolis, MN 55417. The contract is managed by Contracting Officer Traci Johannes. While the solicitation specifies that reagents must meet FDA regulatory categories such as In Vitro Diagnostic (IVD) or Analyte Specific Reagent (ASR), no specific pricing, CLIN structures, or socioeconomic set-asides are applied. Responses are required in the form of a capabilities statement submitted electronically by the August 2026 deadline.
Network Contract Office 23 (36C263)

POSTED

6 days ago

DEADLINE

in 5 days
View Details
NAICS: 325413
New
Federal
Procurement of commercial-off-the-shelf (COTS) proprietary BioFire diagnostic assay kits and refurbished systems
Solicitation # N6817126QN076
The Naval Supply Systems Command Fleet Logistics Center Sigonella intends to award a firm-fixed-price, sole-source purchase order to Bio Fire Defense, LLC for the procurement of proprietary BioFire diagnostic assay kits and four refurbished FilmArray 2.0 systems. This acquisition supports the Naval Medical Research Unit Europe, Africa, Central in its infectious disease surveillance and research operations across Europe, Africa, and the Middle East. The required materials include various specialized panels for global fever, blood culture identification, gastrointestinal, and respiratory diagnostics, all of which must be delivered to NAS II Sigonella, Italy, within 15 calendar days of the order. The sole-source justification is based on the proprietary nature of the consumables and a Foreign Ownership, Control, or Influence mitigation agreement, which mandates that U.S. Federal Government entities procure these specific biological defense assets exclusively through Bio Fire Defense, LLC. While this is a notice of intent for a sole-source award, interested parties may submit capability statements by August 31, 2026. To be considered, respondents must provide evidence of FOCI agreement compliance, the ability to provide exact part numbers without substitutions, cold-chain logistical capabilities for delivery to Italy, and confirmation of valid OEM warranty support.
Navsup Flc Sigonella Naples Office

POSTED

6 days ago

DEADLINE

in 11 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF

Same awarding agency